In vitro susceptibility of African isolates of Plasmodium falciparum from Gabon to pyronaridine.
about
A comparative study of a flow-cytometry-based assessment of in vitro Plasmodium falciparum drug sensitivityIn vitro potentiation of antibiotic activities by a catecholate iron chelator against chloroquine-resistant Plasmodium falciparum.Multinormal in vitro distribution of Plasmodium falciparum susceptibility to piperaquine and pyronaridine.Ex vivo activity of the ACT new components pyronaridine and piperaquine in comparison with conventional ACT drugs against isolates of Plasmodium falciparum.Review of pyronaridine anti-malarial properties and product characteristics.Plasmodium falciparum In Vitro Resistance to Monodesethylamodiaquine, Dakar, Senegal, 2014.Prevalence of anti-malarial resistance genes in Dakar, Senegal from 2013 to 2014.In vitro activity of pyronaridine against Plasmodium falciparum and comparative evaluation of anti-malarial drug susceptibility assaysConfirmation of Plasmodium falciparum in vitro resistance to monodesethylamodiaquine and chloroquine in Dakar, Senegal, in 2015.In vitro studies on the sensitivity pattern of Plasmodium falciparum to anti-malarial drugs and local herbal extractsAbsence of association between pyronaridine in vitro responses and polymorphisms in genes involved in quinoline resistance in Plasmodium falciparum.In vitro activities of antibiotics against Plasmodium falciparum are inhibited by iron.Baseline in vitro activities of the antimalarials pyronaridine and methylene blue against Plasmodium falciparum isolates from Kenya.Antimalarial efficacy of hydroxyethylapoquinine (SN-119) and its derivativesIn Vitro Sensitivity of Pyronaridine in Thai Isolates of Plasmodium falciparum.Identification of Anti-Trypanosoma cruzi Lead Compounds with Putative Immunomodulatory Activity.
P2860
Q33562855-41CA0577-2A4D-41BF-B5D0-2FC4308AC03DQ34104791-F17A5F7D-9315-442A-B2D0-30EA937E554FQ35068138-780CEAF4-320F-4571-80DB-6E84D7AC4E1BQ35834198-AFF249C1-E025-4074-BD2E-08B97BCC4D62Q36353708-1BBB1BE4-EA48-4203-96F0-24297EFE7B4FQ36884930-B8932A4B-F526-4BB7-BCAF-A0ABEA6B2AF9Q37077079-BBE0A86E-284C-48EB-B191-649330DC0DA5Q37184295-9B3F6E3A-3FEB-4C9E-B249-297C7D41F9EBQ37708245-F7A814FD-EF16-4824-949F-EE3FB47F4251Q37717358-722B1414-23C8-48D1-A696-E832F1A8D64FQ39402508-45F1E26C-76BB-4233-AED1-3B76E6B00A89Q39477444-5354446B-9579-40E0-B8F0-9A621BE99D66Q40600918-6AE3B274-D5C9-43EC-93C8-E7837BF8D3B6Q41907557-99B0B4CB-96E7-489D-B0B5-9761B3FA5411Q48016699-80609EB5-1E4B-4171-8A49-7FC5BFBB377EQ50044327-10C304FE-AE2B-47F7-8F0F-FD30C1590787
P2860
In vitro susceptibility of African isolates of Plasmodium falciparum from Gabon to pyronaridine.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
In vitro susceptibility of Afr ...... um from Gabon to pyronaridine.
@en
type
label
In vitro susceptibility of Afr ...... um from Gabon to pyronaridine.
@en
prefLabel
In vitro susceptibility of Afr ...... um from Gabon to pyronaridine.
@en
P2093
P1476
In vitro susceptibility of Afr ...... rum from Gabon to pyronaridine
@en
P2093
B Pradines
J R Mourou Mbina
M Mabika Mamfoumbi
M Owono Medang
P304
P356
10.4269/AJTMH.1999.60.105
P407
P577
1999-01-01T00:00:00Z